BioLargo, Inc.
BLGO
$0.18
$0.013.94%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 4.55M | 3.47M | 2.56M | 3.55M | 3.88M |
| Total Receivables | 761.00K | 5.22M | 4.21M | 3.17M | 3.21M |
| Inventory | 409.00K | 444.00K | 369.00K | 330.00K | 238.00K |
| Prepaid Expenses | 59.00K | 51.00K | 77.00K | 91.00K | 65.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 5.78M | 9.19M | 7.22M | 7.14M | 7.39M |
|
|
|||||
| Total Current Assets | 5.78M | 9.19M | 7.22M | 7.14M | 7.39M |
| Net Property, Plant & Equipment | 3.13M | 3.02M | 3.10M | 3.19M | 2.83M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 34.00K | -- | -- | -- | 34.00K |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 164.00K | 270.00K | 177.00K | 177.00K | 36.00K |
| Total Assets | 9.13M | 12.50M | 10.51M | 10.51M | 10.31M |
|
|
|||||
| Total Accounts Payable | 1.05M | 1.58M | 1.51M | 1.07M | 2.23M |
| Total Accrued Expenses | 122.00K | 270.00K | 96.00K | 150.00K | 66.00K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.35M | 1.31M | 1.01M | 745.00K | 305.00K |
| Total Finance Division Other Current Liabilities | 929.00K | 920.00K | 766.00K | 680.00K | 602.00K |
| Total Other Current Liabilities | 929.00K | 920.00K | 766.00K | 680.00K | 602.00K |
| Total Current Liabilities | 3.45M | 4.08M | 3.37M | 2.65M | 3.20M |
|
|
|||||
| Total Current Liabilities | 3.45M | 4.08M | 3.37M | 2.65M | 3.20M |
| Long-Term Debt | 1.20M | 1.17M | 812.00K | 527.00K | 180.00K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 1.26M | 1.19M | 1.24M | 1.28M | 944.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 5.92M | 6.44M | 5.42M | 4.46M | 4.32M |
|
|
|||||
| Common Stock & APIC | 165.10M | 160.81M | 158.47M | 158.53M | 157.29M |
| Retained Earnings | -158.33M | -151.85M | -150.66M | -149.50M | -148.49M |
| Treasury Stock & Other | -195.00K | -203.00K | -203.00K | -183.00K | -230.00K |
| Total Common Equity | 6.58M | 8.76M | 7.61M | 8.85M | 8.58M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 6.58M | 8.76M | 7.61M | 8.85M | 8.58M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -3.37M | -2.70M | -2.52M | -2.80M | -2.60M |
| Total Equity | 3.22M | 6.06M | 5.09M | 6.06M | 5.98M |
|
|
|||||